Axicabtagene Ciloleucel in Patients with Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1

被引:1
作者
Locke, Frederick L. [1 ]
Ghobadi, Armin [2 ]
Lekakis, Lazaros J. [3 ]
Miklos, David B. [4 ]
Jacobson, Caron A. [5 ]
Jacobsen, Eric [5 ]
Braunschweig, Ira [6 ]
Oluwole, Olalekan O. [7 ]
Siddiqi, Tanya [8 ]
Lin, Yi [9 ]
Reagan, Patrick M. [10 ]
Farooq, Umar [11 ]
Deol, Abhinav [12 ]
Bot, Adrian [13 ]
Rossi, John M. [13 ]
Jiang, Yizhou [13 ]
Xue, Allen [13 ]
Go, William Y. [13 ]
Neelapu, Sattva S. [14 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Univ Miami Hlth Syst, Sylvester Comprehens Care Ctr, Miami, FL USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
[7] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[8] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[9] Mayo Clin, Rochester, MN USA
[10] Univ Rochester, Sch Med, Rochester, NY USA
[11] Univ Iowa, Iowa City, IA USA
[12] Wayne State Univ, Karmanos Canc Ctr, Detroit, MI USA
[13] Kite, Santa Monica, CA USA
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
CAR T cell therapy; large B cell lymphoma;
D O I
10.1016/j.clml.2018.07.203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NHL-102
引用
收藏
页码:S276 / S276
页数:1
相关论文
empty
未找到相关数据